FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Hangzhou Tigermed Consulting Co., Ltd. Stock AnalysisComprehensive stock analysis for Hangzhou Tigermed Consulting Co., Ltd. (HNGZY) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisHNGZY
HNGZY
Hangzhou Tigermed Consulting Co., Ltd.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
HNGZY
Home🔹Stocks🔹Hangzhou Tigermed Consulting Co., Ltd.

Hangzhou Tigermed Consulting Co., Ltd.

HNGZY•OTC

Hangzhou Tigermed Consulting Co., Ltd.

HNGZY•OTC
Market cap
$6.16B
Sentiment

Your view on HNGZY

Mkt Cap
$6.16B
Sentiment
Your view
HNGZY
Hangzhou Tigermed Consulting Co., Ltd.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
HNGZY
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Hangzhou Tigermed Consulting Co., Ltd.

Industry
Medical - Diagnostics & Research
Sector
Healthcare
CEO
Xiaoping Ye D.Phil
Headquarters
F18, Building A – Shengda Science Park, Hangzhou, CN
Industry
Medical - Diagnostics & Research
Sector
Healthcare
CEO
Xiaoping Ye D.Phil
Headquarters
F18, Building A – Shengda Science Park, Hangzhou, CN
Description

Hangzhou Tigermed Consulting Co., Ltd. provides contract research organization services in the People's Republic of China and internationally. It operates in Clinical Trial Solutions, and Clinical-related and Laboratory Services segments. The company offers regulatory submission and approval, medical translation, and good manufacturing practice (GMP) consulting services; and clinical services in the areas of medical science, early clinical and late phase development, medical monitoring, project management, patient recruitment, and quality management system. It also provides biometrics services comprising data management, biostatistics, and statistical programming; and integrated technology services, such as site management, pharmacovigilance, third party audit and training, medical imaging, clinical trial system solution, central laboratory, pre-clinical, and research hospital. Further, the company offers medical device/ in vitro diagnostics (IVD) services comprising medical device testing, regulatory submission, clinical evaluation and trials, GMP certificate, EU MDR and IVDR preparation, and value-added services; and post-marketing study, real world evidence, and vaccine clinical trial services. Hangzhou Tigermed Consulting Co., Ltd. was incorporated in 2004 and is headquartered in Hangzhou, the People's Republic of China.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News